Chemomab Therapeutics earnings dates
Chemomab Therapeutics (CMMB) filed its latest results announcement (Form 8-K, Item 2.02) on May 11, 2023. Over the last three years it filed them in mid May and mid August. The data provider lists Mar 17, 2027 as the next date; that is not a filing and it can change.
Results announcements, newest first
| Filed on | Day | Stock move, 2 days | Filing |
|---|---|---|---|
| Mar 17, 2027listed by the data provider, not filed yet | Wed | — | — |
| May 11, 2023 | Thu | — | 8-K |
| Feb 21, 2023 | Tue | — | 8-K |
| Aug 12, 2022 | Fri | — | 8-K |
| May 12, 2022 | Thu | — | 8-K |
| Mar 9, 2022 | Wed | — | 8-K |
| Nov 12, 2021 | Fri | — | 8-K |
The move runs from the last close before the filing day to the first close after it, so it covers an announcement made before the open or after the close. Prices are adjusted for splits and dividends; “—” means no prices are stored for those days.
The latest quarter’s figures and insider trades around results: Chemomab Therapeutics (CMMB) on OQRO. Every company’s insiders around their results: insider trades around earnings.
Common questions
When does Chemomab Therapeutics report earnings?
Chemomab Therapeutics (CMMB) filed its latest results announcement (Form 8-K, Item 2.02) on May 11, 2023. Over the last three years it filed them in mid May and mid August. The data provider lists Mar 17, 2027 as the next date; that is not a filing and it can change.
How many results announcements has Chemomab Therapeutics filed?
8 since May 13, 2021 in the SEC's EDGAR records, about 3.5 a year lately. A company can file more than four a year when it also releases preliminary figures.
Where these figures come from
Dates are the filing dates of the company’s Form 8-K reports with Item 2.02 (“Results of Operations and Financial Condition”) in the SEC’s EDGAR records. Two such filings within a week count as one announcement. The list is read again every day.
OQRO does not predict the next date. When the data provider lists one, it appears at the top, marked as not filed. This page describes the past and is not investment advice. No language model wrote it.
